|CrossRef Text and Data Mining|
|Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.|
|Chemotherapy in Advanced Urothelial Carcinoma|
|Yun-Sok Ha, Tae-Hwan Kim|
|Korean J Urol Oncol. 2016;14(2):47-53. Published online 2016 August 30 DOI: https://doi.org/10.22465/kjuo.2016.14.2.47|
Triplet chemotherapy with paclitaxel, gemcitabine, and cisplatin as second-line therapy for advanced urothelial carcinoma
Phase I/II study of a combined gemcitabine, etoposide, and cisplatin chemotherapy regimen for metastatic urothelial carcinoma
Adjuvant chemotherapy for high-risk urothelial transitional cell carcinoma: the Princess Margaret Hospital experience
Gemcitabine and paclitaxel chemotherapy as a second-line treatment for advanced or metastatic urothelial carcinoma
Preliminary results of chemotherapy with Ifosfamid and VP 16 in advanced urothelial carcinoma
Chemotherapy in Advanced Urothelial Carcinoma
648 THE EFFICACY OF ADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED UPPER TRACT UROTHELIAL CARCINOMA
Toxicity and Results of MVAC (Methotrexate, Vinblastine, Adriamycin and Cisplatin) Chemotherapy in Advanced Urothelial Carcinoma
Do elderly patients with advanced urothelial carcinoma benefit from platinum-based chemotherapy?
Does HER2 Immunoreactivity Provide Prognostic Information in Locally Advanced Urothelial Carcinoma Patients Receiving Adjuvant M-VEC Chemotherapy?